Galderma (SIX: GALD), the pure-play dermatology category leader, has announced the launch of Restylane Defyne and Restylane Refyne: the first OBT‑based hyaluronic acid injectables ever authorized in ...

While modern dermal fillers have been around for nearly two decades, they've seen a huge bump in popularity in the last few years. And it seems the stigma around facial enhancements like filler and ...